Hepatitis B Vaccine
Hepatitis B Prevention
Key Facts
About Sinopharm
Sinopharm is a Fortune Global 500 company and China's largest pharmaceutical conglomerate, encompassing drug distribution, manufacturing, research and development, and healthcare services. The company gained global recognition for developing one of China's first approved COVID-19 vaccines (BBIBP-CorV) and has established itself as a key player in international vaccine diplomacy. With operations spanning across multiple therapeutic areas and a vast distribution network, Sinopharm serves as a critical component of China's healthcare infrastructure.
View full company profileAbout Zhifei Biological Products
Zhifei Biological Products is a major force in China's vaccine industry, with a mission to develop and provide high-quality, accessible vaccines to prevent infectious diseases. Its key achievements include the successful commercialization of a recombinant human papillomavirus (HPV) vaccine, a recombinant COVID-19 vaccine, and a portfolio of other preventive vaccines. The company's strategic direction focuses on leveraging its R&D and manufacturing capabilities to expand its product pipeline and solidify its domestic leadership while exploring international opportunities.
View full company profileTherapeutic Areas
Other Hepatitis B Prevention Drugs
| Drug | Company | Phase |
|---|---|---|
| Hepatitis B Vaccine (Recombinant) | Hualan Biological Engineering | Approved |